Carl Sailer
Vermogen: 10 237 $ op 31-07-2026
Vermogen: 10 237 $ op 31-07-2026
Carl V.
Sailer currently works at Acurx Pharmaceuticals, Inc., as Independent Director from 2018 and Syneos Health, Inc., as Vice President-Global Client Solutions from 2019.
Mr. Sailer also formerly worked at Emisphere Technologies, Inc., as Vice President-Sales & Marketing from 2012 to 2019, Interpace Biosciences, Inc., as Vice President-Product Commercialization, Akrimax Pharmaceuticals LLC, as Vice President-Commercial Operations from 2008 to 2010, and New American Therapeutics, Inc., as Vice President-Product Commercialization from 2010 to 2012.
Mr. Sailer received his Masters Business Admin degree from Hofstra University and undergraduate degree from Seton Hall University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 7.109 ( 0,45% ) | 10 237 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 23-10-2018 |
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 01-05-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Verkoop & Marketing | 01-03-2019 |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Corporate Officer/Principal | 01-09-2012 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Corporate Officer/Principal | 01-07-2010 |
| INTERPACE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Interpace Biosciences, Inc.
Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Health Technology |
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Health Technology |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops antibiotics for infections caused by bacteria | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau